Structure Therapeutics Inc ADR [GPCR] stock prices are up 4.57% to $29.54 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The GPCR shares have gain 5.88% over the last week, with a monthly amount drifted -13.14%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Structure Therapeutics Inc ADR [NASDAQ: GPCR] stock has seen the most recent analyst activity on December 04, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $80. Previously, Morgan Stanley started tracking the stock with Overweight rating on September 23, 2024, and set its price target to $118. On May 21, 2024, JP Morgan initiated with a Overweight rating and assigned a price target of $65 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $65 on April 09, 2024. JMP Securities initiated its recommendation with a Mkt Outperform and recommended $90 as its price target on October 19, 2023. Piper Sandler started tracking with a Overweight rating for this stock on July 27, 2023, and assigned it a price target of $58.
The stock price of Structure Therapeutics Inc ADR [GPCR] has been fluctuating between $26.23 and $62.74 over the past year. Currently, Wall Street analysts expect the stock to reach $99 within the next 12 months. Structure Therapeutics Inc ADR [NASDAQ: GPCR] shares were valued at $29.54 at the most recent close of the market. An investor can expect a potential return of 235.14% based on the average GPCR price forecast.
Analyzing the GPCR fundamentals
Gross Profit Margin for this corporation currently stands at 0.12% with Operating Profit Margin at -107.05%, Pretax Profit Margin comes in at -83.35%, and Net Profit Margin reading is -83.25%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.16 and Total Capital is -0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.25 points at the first support level, and at 26.96 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.63, and for the 2nd resistance point, it is at 31.72.
Ratios To Look Out For
It’s worth pointing out that Structure Therapeutics Inc ADR [NASDAQ:GPCR]’s Current Ratio is 27.63. On the other hand, the Quick Ratio is 27.63, and the Cash Ratio is 5.15.
